12.06.22 -- What's Wrong With The Medtech R&D Department?

Explore how to address the gradual unlinking of economic activity from consumption of finite resources and removal of waste to support and help prevent a global climate catastrophe.

The production of recombinant collagen made via fermentation-based processes addresses market needs for collagen that is safe, sustainable, reproducible, and acceptable to consumers. 

The life sciences industry is poised to undergo a rapid transformation as regulatory agencies are aggressively opening the door wider to the use of computer modeling and simulation results as evidence in submissions. This webinar will explore how modeling and simulation are able to reduce time and costs and accelerate innovation to achieve the ultimate goal of improving patient outcomes.

RFID technology helps manufacturers relying on repeat sales of consumable components to combat threats to profitability and performance while ensuring superior operability for their end-use customers. This white paper further discusses the benefits of RFID technology and presents five ways that it may be used to optimize consumables programs.

This white paper examines the dynamic regulatory environment of drug-device combination products and provides concrete steps to take to navigate regulatory complexities and decrease time-to-market.

A product’s manufacturability is influenced by the materials used, requested tolerances, part geometry, process control limitations, and more. A successful DFM process considers each of these factors from the start.

When we talk about partnering with OEMs, we often reference the fact that we have a very robust quality management system (QMS). It sounds great, but what does it mean for you, and what does it mean for us, on a day-to-day basis? Why is it imperative that both organizations have an understanding of each other’s QMS?